Bruker (BRKR) – Business Wire
-
Bruker to Acquire the NanoString Business in an Asset Deal
-
Bruker Introduces Novel NMR Scientific Capabilities for Structural Biology Discoveries in Membrane Proteins and Protein Aggregates
-
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
-
Bruker Selected as ‘Company of the Year’ by Instrument Business Outlook
-
Bruker Advances CCS-Enabled 4D-Proteomics timsTOF Solutions for Immunopeptidomes and Glycoproteomics at US HUPO
-
Bruker Announces Closing of Chemspeed Technologies AG Acquisition
-
Bruker Announces Share Purchase Agreement to Acquire Molecular Diagnostics Innovator ELITechGroup
-
Bruker Corporation to Present at Upcoming Investor Conferences
-
Bruker Announces Quarterly Dividend
-
Bruker Reports Fourth Quarter and Full Year 2023 Financial Results
-
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
-
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
-
Bruker Introduces the Ingenious Novel ‘Triceratops’ SPR #64 Surface Plasmon Resonance System for Drug Discovery at SLAS2024
-
Bruker Announces Agreement to Acquire Chemspeed
-
Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts
-
Bruker Announces Acquisition of Tornado Spectral Systems to Expand Its Biopharma Process Analytical Technology (PAT) Product Portfolio
-
Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Bruker Acquires Electron Microscopy Company Nion
-
Bruker Announces First 1.2 GHz NMR Installation in the United States at The Ohio State University - Funded by the U.S. National Science Foundation
-
Bruker Announces Quarterly Dividend
-
Bruker Corporation to Participate in the 2023 Jefferies London Healthcare Conference
-
Bruker Reports Third Quarter 2023 Financial Results
-
Bruker Announces Date and Time of Third Quarter 2023 Earnings Release and Webcast
-
Bruker Announces Majority Investment in MIRO Analytical AG, an Innovator in Compact, Highest-Precision QCL-Based Multi-Gas Analyzers (MGA)
-
Bruker Completes Acquisition of PhenomeX
-
Bruker Introduces Next-Generation Nanomechanical Test System
-
Bruker Introduces Novel 4D-Proteomics™ timsTOF® Capabilities
-
Bruker Announces New Fraport AG Framework Contract for ETD Systems
-
Bruker Corporation to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
-
Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
-
Bruker to Provide 60 Explosives Trace Detectors for Zuerich Airport
-
Bruker Announces Quarterly Dividend
-
Bruker Reports Second Quarter 2023 Financial Results
-
Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast
-
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
-
Bruker Announces SciY™ Platform of Advanced Scientific and Automation Software Solutions for the Digital Transformation of the Life Science and Biopharma Industries
-
Bruker Announces New D6 PHASERTM Benchtop X-Ray Diffraction (XRD) Platform for Materials Analysis and Advanced Research
-
Bruker Releases 2023 Sustainability Report
-
PreOmics Introduces New ENRICH-iST Kits and Novel Workflow for Unbiased, Affordable Plasma and Serum Proteomics by LC-MS
-
Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™
-
Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments
-
Bruker Corporation to Present at Jefferies 2023 Healthcare Conference
-
Bruker to Host Investor Day on June 15th, 2023
-
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board Declares Quarterly Dividend
-
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions
-
Bruker Reports First Quarter 2023 Financial Results
-
Bruker Announces Date and Time of First Quarter 2023 Earnings Release and Webcast
-
Bruker Advances NMR Magnet Portfolio, Innovates in Industrial Solutions
-
Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, and a Novel LiquidArray® Gastrointestinal Syndromic Panel
-
PreOmics Introduces a Novel BeatBox™ FFPE Workflow for Accelerated, In-depth Tissue Proteomics
Back to BRKR Stock Lookup
